We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
156 hedge funds and large institutions have $824M invested in Corcept Therapeutics in 2017 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 68 increasing their positions, 38 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
257% more call options, than puts
Call options by funds: $2.4M | Put options by funds: $673K
162% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 13
79% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 38
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
24% more capital invested
Capital invested by funds: $664M → $824M (+$160M)
16% more funds holding
Funds holding: 135 → 156 (+21)
8% more ownership
Funds ownership: 53.69% → 61.7% (+8%)
Holders
156
Holders Change
+21
Holders Change %
+15.56%
% of All Funds
3.89%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.12%
New
34
Increased
68
Reduced
38
Closed
13
Calls
$2.4M
Puts
$673K
Net Calls
+$1.73M
Net Calls Change
-$13K
Top Buyers
| 1 |
MWNA
Marshall Wace North America
New York
|
+$12.6M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$11.6M |
| 3 |
Renaissance Technologies
New York
|
+$8.97M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.5M |
| 5 |
CCM
Consonance Capital Management
New York
|
+$6.9M |
Top Sellers
| 1 |
ISL
Ingalls & Snyder LLC
New York
|
-$5.76M |
| 2 |
Morgan Stanley
New York
|
-$5.61M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$4.51M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$4.39M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$2.82M |
